Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial11The MUCHA committee members are listed in the Appendix.-Reference-Cited by-同舟云学术

Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial11The MUCHA committee members are listed in the Appendix.

Published:2004-02 Issue:2 Volume:147 Page:324-330
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Hori Masatsugu,Sasayama Shigetake,Kitabatake Akira,Toyo-oka Teruhiko,Handa Shunnosuke,Yokoyama Mitsuhiro,Matsuzaki Masunori,Takeshita Akira,Origasa Hideki,Matsui Kennichi,Hosoda Saichi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure;Packer;N Engl J Med,1996

2. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease;Lancet,1997

3. Effect of carvedilol on survival in severe chronic heart failure;Packer;N Engl J Med,2001

4. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II);Lancet,1999

5. Effect of metoprolol CR/XL in chronic heart failure;Lancet,1999

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study;PLOS ONE;2024-03-07

2. Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial;The Lancet Oncology;2024-02

3. Implementation of evidence-based heart failure management: Regional variations between Japan and the USA;Journal of Cardiology;2024-02

4. β-Blockers, Central Sympathetic Agents, and Direct Vasodilators;Hypertension;2024

5. Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients　― A Report From the West Tokyo Heart Failure Registry ―;Circulation Journal;2023-12-25